In this video, Pr Dominik Selleslag discusses why every patient with AML should be tested for FLT3, not only at diagnosis but also after relapse. Patients can become FLT3 positive and then they can benefit from FLT3 inhibition.
Intended for: practitioners Why: up-to-date knowledge When: watch now Language: English Duration: 6 minutes